Psoriasis and Non Alcoholic Steatohepatitis: Is There a Shared Inflammatory Network ?

A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

NCT05809934 ·Status: COMPLETED ·Phase: PHASE2

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT05395481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH

NCT05945537 ·Status: RECRUITING ·Phase: PHASE1

An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLD

NCT03868566 ·Status: TERMINATED ·Phase: PHASE2

Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis

NCT00470171 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis

NCT04255069 ·Status: UNKNOWN ·Phase: PHASE2

A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis

NCT02316717 ·Status: COMPLETED ·Phase: PHASE2

Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy

NCT07255781 ·Status: WITHDRAWN

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

NCT04929483 ·Status: COMPLETED ·Phase: PHASE2

A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis

NCT00492700 ·Status: COMPLETED ·Phase: PHASE2

THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)

NCT04925362 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

NCT06613698 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

NCT06739486 ·Status: NOT_YET_RECRUITING

The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis

NCT05065593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

NCT06342947 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

NCT04880187 ·Status: UNKNOWN ·Phase: PHASE2

Non-alcoholic Steatohepatitis Registry Platform Study

NCT06123858 ·Status: TERMINATED

Phase 2b Study of GSK4532990 in Adults With NASH

NCT05583344 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Influence of Diabetic Control on the Degree of Liver Fibrosis Assessed by Non-invasive Scores in Patients Followed in Diabetology

NCT05605821 ·Status: NOT_YET_RECRUITING

Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)

NCT01694849 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

NCT06318169 ·Status: RECRUITING ·Phase: PHASE3

Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical Study

NCT01791452 ·Status: UNKNOWN

Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)

NCT03912532 ·Status: COMPLETED ·Phase: PHASE2

Non Alcoholic Fatty Liver Disease Influence of Statin Therapy

NCT00375349 ·Status: WITHDRAWN ·Phase: NA

IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)

NCT05989711 ·Status: COMPLETED ·Phase: PHASE2